论文部分内容阅读
在过去的三年里,我们曾逐年地综述了上一年度国内鉴定的新药,以便读者对鉴定的新药品种及其药理作用和临床评价有一个概略的了解。遗憾的是难以避免有漏写的品种。为了尽可能更全面地和更及时地报道国内新药研制的成果,以促进新药的正式投产与推广应用,从今年开始将跨年度地进行综述。今年综述1980～1981年内鉴定的新药,少数未列入的品种,将在1983年刊出的1981～1982年国内新药综述中介绍。本文介绍的新药共38种,其中属创制性的计17种,仿制药物有19种,复方药1种,另1种为新用途的老药。尚有几个通过鉴定的药物是不同试制单位重复鉴定的品种,过去已有报道,这里从略。
In the past three years, we reviewed annually the new nationally identified new drugs in the past year so that readers have a general idea about the identified new drug classes, their pharmacological effects and clinical evaluation. Unfortunately, it is difficult to avoid missing write varieties. In order to cover as much as possible the more comprehensive and timely reports of the results of the development of new drugs in China so as to promote the formal launch and promotion of new drugs, a review will be conducted on a multi-year basis beginning this year. This year reviews the new drugs identified in 1980-1981. A few non-listed varieties will be introduced in the 1983-1981 domestic pharmaceutical review published in 1983. This article describes a total of 38 kinds of new drugs, of which there are 17 kinds of generative, 19 kinds of generic drugs, 1 kinds of compound drugs, and the other for a new type of old drugs. There are a few passed the identification of the drug is a different trial units repeated identification of species, in the past have been reported here omitted.